Tanja Morath - Concepedia

Author

Tanja Morath

Klinikum rechts der Isar

Also Known As

Barbara von Merzljak, J. Ruf, Julia Stegherr, Martin Hadamitzky, Siegmund Braun, T. MORATH, T. Morath, Tanja Morath

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Klinikum rechts der Isar Deutsches Herzzentrum München Technical University of Munich Deutsches Herzzentrum der Charité German Centre for Cardiovascular Research

About

Tanja Morath is an author at Klinikum rechts der Isar specializing in medicine, cardiovascular disease, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.5K
2	Emergency Medicine	4	4	465
3	Health Sciences	3	3	87
4	Public Health	1	1	27
5	Epidemiology	1	1	27

Tanja Morath

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis Dirk Sibbing, Siegmund Braun, Tanja Morath, Journal of the American College of Cardiology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletPharmacology	2009	646
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement Dirk Sibbing, Werner Koch, Daniela Gebhard, Circulation	2010	580
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting Stefanie Schüpke, Robert A. Byrne, Jurriën M. ten Berg, European Heart Journal	2015	423
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention Dirk Sibbing, Julia Stegherr, Wolfgang Latz, European Heart Journal	2008	416
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement Dirk Sibbing, S. Schulz, S. Braun, Journal of Thrombosis and Haemostasis Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood PlateletCoronary Artery Disease	2009	322
Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture Stefanie Schüpke, Sandra Helde, Senta Gewalt, JAMA	2014	191
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy Dirk Sibbing, Doris Gebhard, Werner Koch, Journal of Thrombosis and Haemostasis	2010	139
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting Tanja Morath, Siegmund Braun, Julia Stegherr, Thrombosis and Haemostasis	2009	134
Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction S. Schulz, Gert Richardt, Karl‐Ludwig Laugwitz, European Heart Journal	2014	107
Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention Katharina Mayer, Isabell Bernlochner, Siegmund Braun, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionAspirin TreatmentCardiovascular DiseaseCardiology	2014	96

Page 1